Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —63.57 K1.64 M—652.28 K181.09 K — Research & development —————— — Operating income —-63.57 K-1.64 M—-652.28 K-181.09 K — Non-Operating Income, Total —1 8641.25 M—1.6 M1.6 M — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —1 8641.25 M—1.6 M1.6 M — Unusual income/expense —————— — Pretax income —-61.71 K-395.37 K—943.36 K1.42 M — Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations —-61.71 K-395.37 K—943.36 K1.42 M — Discontinued operations —————— — Net income —-61.71 K-395.37 K—943.36 K1.42 M — Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders —92.13 K395.37 K—943.36 K1.42 M — Basic earnings per share (Basic EPS) —0.120.12—0.240.36 — Diluted earnings per share (Diluted EPS) —0.120.12—0.240.36 — Average basic shares outstanding 5 M10.31 M26.3 M32.62 M47.16 M47.16 M — Diluted shares outstanding 5 M11.8 M27.14 M33.06 M47.16 M47.16 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —